<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-09-26" modified="2020-08-12" version="171">
<accession>Q9H8V3</accession>
<accession>Q0MT80</accession>
<accession>Q2M269</accession>
<accession>Q6U836</accession>
<accession>Q9NSV8</accession>
<accession>Q9NVW9</accession>
<name>ECT2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein ECT2</fullName>
</recommendedName>
<alternativeName>
<fullName>Epithelial cell-transforming sequence 2 oncogene</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ECT2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="J. Cell Biol." volume="147" first="921" last="928">
<title>Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis.</title>
<authorList>
<person name="Tatsumoto T."/>
<person name="Xie X."/>
<person name="Blumenthal R."/>
<person name="Okamoto I."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="10579713"/>
<dbReference type="DOI" id="10.1083/jcb.147.5.921"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2003" name="J. Cell. Biochem." volume="90" first="819" last="836">
<title>Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains.</title>
<authorList>
<person name="Saito S."/>
<person name="Tatsumoto T."/>
<person name="Lorenzi M.V."/>
<person name="Chedid M."/>
<person name="Kapoor V."/>
<person name="Sakata H."/>
<person name="Rubin J.S."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="14587037"/>
<dbReference type="DOI" id="10.1002/jcb.10688"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="1432" last="1440">
<title>The armadillo protein p0071 regulates Rho signalling during cytokinesis.</title>
<authorList>
<person name="Wolf A."/>
<person name="Keil R."/>
<person name="Gotzl O."/>
<person name="Mun A."/>
<person name="Schwarze K."/>
<person name="Lederer M."/>
<person name="Huttelmaier S."/>
<person name="Hatzfeld M."/>
</authorList>
<dbReference type="PubMed" id="17115030"/>
<dbReference type="DOI" id="10.1038/ncb1504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH PKP4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Teratocarcinoma</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 662-914 (ISOFORM 3)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7169" last="7179">
<title>Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation.</title>
<authorList>
<person name="Saito S."/>
<person name="Liu X.F."/>
<person name="Kamijo K."/>
<person name="Raziuddin R."/>
<person name="Tatsumoto T."/>
<person name="Okamoto I."/>
<person name="Chen X."/>
<person name="Lee C.C."/>
<person name="Lorenzi M.V."/>
<person name="Ohara N."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="14645260"/>
<dbReference type="DOI" id="10.1074/jbc.m306725200"/>
</citation>
<scope>FUNCTION</scope>
<scope>HOMODIMERIZATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 379-ARG--ARG-381; 402-ARG--ARG-404 AND 596-PRO--ARG-599</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="6665" last="6675">
<title>Nucleotide exchange factor ECT2 interacts with the polarity protein complex Par6/Par3/protein kinase Czeta (PKCzeta) and regulates PKCzeta activity.</title>
<authorList>
<person name="Liu X.F."/>
<person name="Ishida H."/>
<person name="Raziuddin R."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="15254234"/>
<dbReference type="DOI" id="10.1128/mcb.24.15.6665-6675.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PARD3; PARD6A; PARD6B AND PRKCQ</scope>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="5733" last="5739">
<title>The tandem BRCT domains of Ect2 are required for both negative and positive regulation of Ect2 in cytokinesis.</title>
<authorList>
<person name="Kim J.E."/>
<person name="Billadeau D.D."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="15545273"/>
<dbReference type="DOI" id="10.1074/jbc.m409298200"/>
</citation>
<scope>FUNCTION</scope>
<scope>HOMODIMERIZATION</scope>
<scope>HOMOOLIGOMERIZATION</scope>
<scope>MUTAGENESIS OF TRP-336</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="168" first="221" last="232">
<title>Ect2 and MgcRacGAP regulate the activation and function of Cdc42 in mitosis.</title>
<authorList>
<person name="Oceguera-Yanez F."/>
<person name="Kimura K."/>
<person name="Yasuda S."/>
<person name="Higashida C."/>
<person name="Kitamura T."/>
<person name="Hiraoka Y."/>
<person name="Haraguchi T."/>
<person name="Narumiya S."/>
</authorList>
<dbReference type="PubMed" id="15642749"/>
<dbReference type="DOI" id="10.1083/jcb.200408085"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="170" first="571" last="582">
<title>An ECT2-centralspindlin complex regulates the localization and function of RhoA.</title>
<authorList>
<person name="Yuce O."/>
<person name="Piekny A."/>
<person name="Glotzer M."/>
</authorList>
<dbReference type="PubMed" id="16103226"/>
<dbReference type="DOI" id="10.1083/jcb.200501097"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RACGAP1</scope>
<scope>MUTAGENESIS OF THR-373</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="13158" last="13163">
<title>MgcRacGAP controls the assembly of the contractile ring and the initiation of cytokinesis.</title>
<authorList>
<person name="Zhao W.-M."/>
<person name="Fang G."/>
</authorList>
<dbReference type="PubMed" id="16129829"/>
<dbReference type="DOI" id="10.1073/pnas.0504145102"/>
</citation>
<scope>INTERACTION WITH RACGAP1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell. Signal." volume="18" first="1604" last="1615">
<title>Nucleotide exchange factor ECT2 regulates epithelial cell polarity.</title>
<authorList>
<person name="Liu X.F."/>
<person name="Ohno S."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="16495035"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2006.01.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Mol. Biol. Cell" volume="17" first="43" last="55">
<title>Dissecting the role of Rho-mediated signaling in contractile ring formation.</title>
<authorList>
<person name="Kamijo K."/>
<person name="Ohara N."/>
<person name="Abe M."/>
<person name="Uchimura T."/>
<person name="Hosoya H."/>
<person name="Lee J.S."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="16236794"/>
<dbReference type="DOI" id="10.1091/mbc.e05-06-0569"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE CENTRALSPINDLIN COMPLEX</scope>
<scope>INTERACTION WITH KIF23 AND RACGAP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="566" last="578">
<title>Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase.</title>
<authorList>
<person name="Hara T."/>
<person name="Abe M."/>
<person name="Inoue H."/>
<person name="Yu L.R."/>
<person name="Veenstra T.D."/>
<person name="Kang Y.H."/>
<person name="Lee K.S."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="16170345"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209078"/>
</citation>
<scope>FUNCTION</scope>
<scope>HOMODIMERIZATION</scope>
<scope>PHOSPHORYLATION AT THR-373</scope>
<scope>MUTAGENESIS OF THR-373</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="827" last="837">
<title>Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA.</title>
<authorList>
<person name="Niiya F."/>
<person name="Tatsumoto T."/>
<person name="Lee K.S."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="16247472"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209124"/>
</citation>
<scope>PHOSPHORYLATION AT THR-444</scope>
<scope>INTERACTION WITH PLK1</scope>
<scope>MUTAGENESIS OF THR-444 AND THR-846</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="1791" last="1803">
<title>Sequential Cyk-4 binding to ECT2 and FIP3 regulates cleavage furrow ingression and abscission during cytokinesis.</title>
<authorList>
<person name="Simon G.C."/>
<person name="Schonteich E."/>
<person name="Wu C.C."/>
<person name="Piekny A."/>
<person name="Ekiert D."/>
<person name="Yu X."/>
<person name="Gould G.W."/>
<person name="Glotzer M."/>
<person name="Prekeris R."/>
</authorList>
<dbReference type="PubMed" id="18511905"/>
<dbReference type="DOI" id="10.1038/emboj.2008.112"/>
</citation>
<scope>INTERACTION WITH RAB11FIP3</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; SER-370; THR-373; SER-376; SER-842 AND THR-846</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Mol. Biol. Cell" volume="20" first="1428" last="1440">
<title>Centrosome/spindle pole-associated protein regulates cytokinesis via promoting the recruitment of MyoGEF to the central spindle.</title>
<authorList>
<person name="Asiedu M."/>
<person name="Wu D."/>
<person name="Matsumura F."/>
<person name="Wei Q."/>
</authorList>
<dbReference type="PubMed" id="19129481"/>
<dbReference type="DOI" id="10.1091/mbc.e08-01-0001"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Oncogene" volume="28" first="3597" last="3607">
<title>Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.</title>
<authorList>
<person name="Justilien V."/>
<person name="Fields A.P."/>
</authorList>
<dbReference type="PubMed" id="19617897"/>
<dbReference type="DOI" id="10.1038/onc.2009.217"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PARD6A AND PRKCI</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E1000110" last="E1000110">
<title>Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation.</title>
<authorList>
<person name="Wolfe B.A."/>
<person name="Takaki T."/>
<person name="Petronczki M."/>
<person name="Glotzer M."/>
</authorList>
<dbReference type="PubMed" id="19468300"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000110"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KIF23 AND RACGAP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-184 AND LYS-226</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E1000111" last="E1000111">
<title>Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells.</title>
<authorList>
<person name="Burkard M.E."/>
<person name="Maciejowski J."/>
<person name="Rodriguez-Bravo V."/>
<person name="Repka M."/>
<person name="Lowery D.M."/>
<person name="Clauser K.R."/>
<person name="Zhang C."/>
<person name="Shokat K.M."/>
<person name="Carr S.A."/>
<person name="Yaffe M.B."/>
<person name="Jallepalli P.V."/>
</authorList>
<dbReference type="PubMed" id="19468302"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000111"/>
</citation>
<scope>INTERACTION WITH RACGAP1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-359</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="8149" last="8157">
<title>Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.</title>
<authorList>
<person name="Justilien V."/>
<person name="Jameison L."/>
<person name="Der C.J."/>
<person name="Rossman K.L."/>
<person name="Fields A.P."/>
</authorList>
<dbReference type="PubMed" id="21189248"/>
<dbReference type="DOI" id="10.1074/jbc.m110.196113"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-359</scope>
<scope>MUTAGENESIS OF THR-359</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E17108" last="E17108">
<title>The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage.</title>
<authorList>
<person name="Srougi M.C."/>
<person name="Burridge K."/>
</authorList>
<dbReference type="PubMed" id="21373644"/>
<dbReference type="DOI" id="10.1371/journal.pone.0017108"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-359</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-359; SER-367; SER-716; SER-861 AND SER-866</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-611</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="submission" date="2010-01" db="PDB data bank">
<title>Crystal structure of the second BRCT domain of epithelial cell transforming 2 (ECT2).</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.48 ANGSTROMS) OF 268-361</scope>
</reference>
<reference key="34" evidence="2">
<citation type="journal article" date="2014" name="FEBS Lett." volume="588" first="2911" last="2920">
<title>Crystal structure of triple-BRCT-domain of ECT2 and insights into the binding characteristics to CYK-4.</title>
<authorList>
<person name="Zou Y."/>
<person name="Shao Z."/>
<person name="Peng J."/>
<person name="Li F."/>
<person name="Gong D."/>
<person name="Wang C."/>
<person name="Zuo X."/>
<person name="Zhang Z."/>
<person name="Wu J."/>
<person name="Shi Y."/>
<person name="Gong Q."/>
</authorList>
<dbReference type="PubMed" id="25068414"/>
<dbReference type="DOI" id="10.1016/j.febslet.2014.07.019"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.11 ANGSTROMS) OF 45-356</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH RACGAP1</scope>
<scope>MUTAGENESIS OF THR-184 AND LYS-226</scope>
</reference>
<reference key="35" evidence="3">
<citation type="journal article" date="2020" name="Proc. Natl. Acad. Sci. U.S.A." volume="117" first="1027" last="1035">
<title>Structure and regulation of human epithelial cell transforming 2 protein.</title>
<authorList>
<person name="Chen M."/>
<person name="Pan H."/>
<person name="Sun L."/>
<person name="Shi P."/>
<person name="Zhang Y."/>
<person name="Li L."/>
<person name="Huang Y."/>
<person name="Chen J."/>
<person name="Jiang P."/>
<person name="Fang X."/>
<person name="Wu C."/>
<person name="Chen Z."/>
</authorList>
<dbReference type="PubMed" id="31888991"/>
<dbReference type="DOI" id="10.1073/pnas.1913054117"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 173-865</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH RHOA</scope>
<scope>DOMAIN</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF TRP-338; ARG-488; ARG-570; ALA-573; ARG-586; PRO-601; PHE-652; TYR-656; ARG-670; PRO-734 AND CYS-796</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] PRO-833</scope>
</reference>
<comment type="function">
<text evidence="13 14 15 16 17 18 20 21 23 25 26 28 29 30 32 33">Guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP. Promotes guanine nucleotide exchange on the Rho family members of small GTPases, like RHOA, RHOC, RAC1 and CDC42. Required for signal transduction pathways involved in the regulation of cytokinesis. Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Regulates the translocation of RHOA from the central spindle to the equatorial region. Plays a role in the control of mitotic spindle assembly; regulates the activation of CDC42 in metaphase for the process of spindle fibers attachment to kinetochores before chromosome congression. Involved in the regulation of epithelial cell polarity; participates in the formation of epithelial tight junctions in a polarity complex PARD3-PARD6-protein kinase PRKCQ-dependent manner. Plays a role in the regulation of neurite outgrowth. Inhibits phenobarbital (PB)-induced NR1I3 nuclear translocation. Stimulates the activity of RAC1 through its association with the oncogenic PARD6A-PRKCI complex in cancer cells, thereby acting to coordinately drive tumor cell proliferation and invasion. Also stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death.</text>
</comment>
<comment type="activity regulation">
<text evidence="32 33">Autoinhibited by the C-terminal PH domain which folds back and binds to the surface of the DH domain, blocking binding of RHOA to the catalytic center of the DH domain (PubMed:31888991). The 2nd BRCT domain is also involved in inhibition, probably by helping to impede RHOA binding (PubMed:31888991). Allosterically activated by binding of activated GTP-bound RHOA to the PH domain which stimulates the release of PH inhibition and promotes the binding of substrate RHOA to the catalytic center (PubMed:31888991). Binding of phosphorylated RACGAP1 to the N-terminal BRCT domain-containing region also releases autoinhibition (PubMed:25068414).</text>
</comment>
<comment type="subunit">
<text evidence="10 14 15 16 18 19 20 21 22 26 27 28 31 32 33">Homodimer (PubMed:15545273, PubMed:14645260, PubMed:16170345). Homooligomer (PubMed:15545273). Found in the centralspindlin complex (PubMed:16236794). Interacts with NR1I3 (By similarity). Interacts (Thr-359 phosphorylated form) with PARD6A; the interaction is observed in cancer cells (PubMed:15254234, PubMed:19617897). Interacts (Thr-359 phosphorylated form) with PRKCI; the interaction is observed in cancer cells (PubMed:19617897). Interacts with PKP4; the interaction is observed at the midbody (PubMed:22814378). Interacts with RACGAP1/CYK4; the interaction is direct, occurs in a microtubule-dependent manner, occurs at anaphase and during cytokinesis, is inhibited in metaphase by phosphorylation of ECT2 on Thr-373 and is stimulated in early anaphase by dephosphorylation of ECT2 probably on Thr-373 through CDK1 activity (PubMed:16103226, PubMed:16129829, PubMed:16236794, PubMed:19468300, PubMed:19468302, PubMed:25068414). Interacts with PLK1; the interaction is stimulated upon its phosphorylation on Thr-444 (PubMed:16247472). Interacts with RHOA; the interaction results in allosteric activation of ECT2 (PubMed:31888991). Interacts with KIF23, PARD3, PARD6B and PRKCQ (PubMed:15254234, PubMed:16236794).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054039">
<id>Q9H8V3</id>
</interactant>
<interactant intactId="EBI-727477">
<id>P12830</id>
<label>CDH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054039">
<id>Q9H8V3</id>
</interactant>
<interactant intactId="EBI-701918">
<id>P35221</id>
<label>CTNNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054039">
<id>Q9H8V3</id>
</interactant>
<interactant intactId="EBI-306852">
<id>Q02241</id>
<label>KIF23</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054039">
<id>Q9H8V3</id>
</interactant>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054039">
<id>Q9H8V3</id>
</interactant>
<interactant intactId="EBI-746202">
<id>O00444</id>
<label>PLK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054039">
<id>Q9H8V3</id>
</interactant>
<interactant intactId="EBI-717233">
<id>Q9H0H5</id>
<label>RACGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Spindle</location>
</subcellularLocation>
<subcellularLocation>
<location>Cleavage furrow</location>
</subcellularLocation>
<subcellularLocation>
<location>Midbody</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell junction</location>
<location>Tight junction</location>
</subcellularLocation>
<text>Sequestered within the nucleus during interphase. Dispersed throughout the cytoplasm upon breakdown of the nuclear envelope during mitosis. Colocalizes with the centralspindlin complex to the mitotic spindles during anaphase/metaphase, the cleavage furrow during telophase and at the midbody at the end of cytokinesis. Colocalized with RhoA at the midbody. Its subcellular localization to tight junction is increased by calcium. Localized predominantly in the cytoplasm of numerous carcinoma cells.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9H8V3-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9H8V3-2</id>
<name>2</name>
<sequence type="described" ref="VSP_041976 VSP_041977"/>
</isoform>
<isoform>
<id>Q9H8V3-3</id>
<name>3</name>
<sequence type="described" ref="VSP_041978"/>
</isoform>
<isoform>
<id>Q9H8V3-4</id>
<name>4</name>
<sequence type="described" ref="VSP_041977"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="28">Expressed in lung epithelial cells (at protein level). Expressed in squamous cell carcinoma, primary non-small cell lung cancer tumors and lung adenocarcinoma.</text>
</comment>
<comment type="induction">
<text evidence="15 30">Up-regulated by calcium in cells forming cell-cell contact sites. Up-regulated by DNA damaging agents like H(2)O(2) or ionizing radiation (IR).</text>
</comment>
<comment type="domain">
<text evidence="16 33">The BRCT domains 1 and 2 are required for intramolecular interaction, but not for intermolecular oligomerization (PubMed:15545273). The BRCT domains negatively inhibit its GEF activity in interphase cells (PubMed:15545273, PubMed:31888991). The same BRCT domains may act as a positive regulatory motif for the completion of cytokinesis after the breakdown of nuclear membrane during mitosis (PubMed:15545273).</text>
</comment>
<comment type="PTM">
<text evidence="13 20 22 29">Phosphorylated by PLK1 in vitro. Hyperphosphorylated during the G2 phase of the cell cycle. Phosphorylation at Thr-373 occurs during the G2/M phase, relieves its auto-inhibition status and stimulates its GEF activity. Phosphorylation at Thr-444 in G2/M phase is required for subsequent binding with PLK1 and Rho exchange activation. Dephosphorylated at the time of cytokinesis. Phosphorylation at Thr-359 is required for its transformation activity in cancer cells.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="39">May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</comment>
<comment type="sequence caution" evidence="39">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA91624" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ECT2ID40400ch3q26.html"/>
</comment>
<dbReference type="EMBL" id="AY376439">
<property type="protein sequence ID" value="AAQ83675.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ847274">
<property type="protein sequence ID" value="ABH10140.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK001323">
<property type="protein sequence ID" value="BAA91624.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK023267">
<property type="protein sequence ID" value="BAB14498.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314581">
<property type="protein sequence ID" value="BAG37157.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC108667">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112086">
<property type="protein sequence ID" value="AAI12087.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137710">
<property type="protein sequence ID" value="CAB70886.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3220.1">
<molecule id="Q9H8V3-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58860.1">
<molecule id="Q9H8V3-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS87168.1">
<molecule id="Q9H8V3-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001245244.1">
<molecule id="Q9H8V3-1"/>
<property type="nucleotide sequence ID" value="NM_001258315.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001245245.1">
<molecule id="Q9H8V3-4"/>
<property type="nucleotide sequence ID" value="NM_001258316.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_060568.3">
<molecule id="Q9H8V3-4"/>
<property type="nucleotide sequence ID" value="NM_018098.5"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011510816.1">
<molecule id="Q9H8V3-3"/>
<property type="nucleotide sequence ID" value="XM_011512514.2"/>
</dbReference>
<dbReference type="PDB" id="3L46">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.48"/>
<property type="chains" value="A/B=268-361"/>
</dbReference>
<dbReference type="PDB" id="4N40">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.11"/>
<property type="chains" value="A=45-356"/>
</dbReference>
<dbReference type="PDB" id="6L30">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=173-865"/>
</dbReference>
<dbReference type="PDBsum" id="3L46"/>
<dbReference type="PDBsum" id="4N40"/>
<dbReference type="PDBsum" id="6L30"/>
<dbReference type="SMR" id="Q9H8V3"/>
<dbReference type="BioGRID" id="108223">
<property type="interactions" value="161"/>
</dbReference>
<dbReference type="CORUM" id="Q9H8V3"/>
<dbReference type="DIP" id="DIP-47496N"/>
<dbReference type="IntAct" id="Q9H8V3">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="MINT" id="Q9H8V3"/>
<dbReference type="STRING" id="9606.ENSP00000376457"/>
<dbReference type="iPTMnet" id="Q9H8V3"/>
<dbReference type="MetOSite" id="Q9H8V3"/>
<dbReference type="PhosphoSitePlus" id="Q9H8V3"/>
<dbReference type="BioMuta" id="ECT2"/>
<dbReference type="DMDM" id="357529579"/>
<dbReference type="EPD" id="Q9H8V3"/>
<dbReference type="jPOST" id="Q9H8V3"/>
<dbReference type="MassIVE" id="Q9H8V3"/>
<dbReference type="MaxQB" id="Q9H8V3"/>
<dbReference type="PaxDb" id="Q9H8V3"/>
<dbReference type="PeptideAtlas" id="Q9H8V3"/>
<dbReference type="PRIDE" id="Q9H8V3"/>
<dbReference type="ProteomicsDB" id="81243">
<molecule id="Q9H8V3-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="81244">
<molecule id="Q9H8V3-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="81245">
<molecule id="Q9H8V3-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="33733">
<property type="antibodies" value="365 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000232458">
<molecule id="Q9H8V3-4"/>
<property type="protein sequence ID" value="ENSP00000232458"/>
<property type="gene ID" value="ENSG00000114346"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000392692">
<molecule id="Q9H8V3-1"/>
<property type="protein sequence ID" value="ENSP00000376457"/>
<property type="gene ID" value="ENSG00000114346"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000417960">
<molecule id="Q9H8V3-2"/>
<property type="protein sequence ID" value="ENSP00000415876"/>
<property type="gene ID" value="ENSG00000114346"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000441497">
<molecule id="Q9H8V3-4"/>
<property type="protein sequence ID" value="ENSP00000412259"/>
<property type="gene ID" value="ENSG00000114346"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000540509">
<molecule id="Q9H8V3-4"/>
<property type="protein sequence ID" value="ENSP00000443160"/>
<property type="gene ID" value="ENSG00000114346"/>
</dbReference>
<dbReference type="GeneID" id="1894"/>
<dbReference type="KEGG" id="hsa:1894"/>
<dbReference type="UCSC" id="uc003fih.4">
<molecule id="Q9H8V3-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1894"/>
<dbReference type="DisGeNET" id="1894"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000114346.13"/>
<dbReference type="GeneCards" id="ECT2"/>
<dbReference type="HGNC" id="HGNC:3155">
<property type="gene designation" value="ECT2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000114346">
<property type="expression patterns" value="Tissue enhanced (lymphoid)"/>
</dbReference>
<dbReference type="MIM" id="600586">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9H8V3"/>
<dbReference type="OpenTargets" id="ENSG00000114346"/>
<dbReference type="PharmGKB" id="PA27600"/>
<dbReference type="eggNOG" id="KOG3524">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156299"/>
<dbReference type="HOGENOM" id="CLU_008187_0_0_1"/>
<dbReference type="InParanoid" id="Q9H8V3"/>
<dbReference type="KO" id="K20704"/>
<dbReference type="OMA" id="CKAKESN"/>
<dbReference type="OrthoDB" id="557169at2759"/>
<dbReference type="TreeFam" id="TF101161"/>
<dbReference type="PathwayCommons" id="Q9H8V3"/>
<dbReference type="Reactome" id="R-HSA-193648">
<property type="pathway name" value="NRAGE signals death through JNK"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-194840">
<property type="pathway name" value="Rho GTPase cycle"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416482">
<property type="pathway name" value="G alpha (12/13) signalling events"/>
</dbReference>
<dbReference type="SignaLink" id="Q9H8V3"/>
<dbReference type="SIGNOR" id="Q9H8V3"/>
<dbReference type="BioGRID-ORCS" id="1894">
<property type="hits" value="610 hits in 881 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ECT2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9H8V3"/>
<dbReference type="GeneWiki" id="ECT2"/>
<dbReference type="GenomeRNAi" id="1894"/>
<dbReference type="Pharos" id="Q9H8V3">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9H8V3"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="Q9H8V3">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000114346">
<property type="expression patterns" value="Expressed in secondary oocyte and 206 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9H8V3">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9H8V3">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005923">
<property type="term" value="C:bicellular tight junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097149">
<property type="term" value="C:centralspindlin complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032154">
<property type="term" value="C:cleavage furrow"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030496">
<property type="term" value="C:midbody"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072686">
<property type="term" value="C:mitotic spindle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005096">
<property type="term" value="F:GTPase activator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030676">
<property type="term" value="F:Rac guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005089">
<property type="term" value="F:Rho guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090630">
<property type="term" value="P:activation of GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032147">
<property type="term" value="P:activation of protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070830">
<property type="term" value="P:bicellular tight junction assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000902">
<property type="term" value="P:cell morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071277">
<property type="term" value="P:cellular response to calcium ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071479">
<property type="term" value="P:cellular response to ionizing radiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0000281">
<property type="term" value="P:mitotic cytokinesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032467">
<property type="term" value="P:positive regulation of cytokinesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043547">
<property type="term" value="P:positive regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0007001"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045666">
<property type="term" value="P:positive regulation of neuron differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051988">
<property type="term" value="P:regulation of attachment of spindle microtubules to kinetochore"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000431">
<property type="term" value="P:regulation of cytokinesis, actomyosin contractile ring assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0045859">
<property type="term" value="P:regulation of protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051056">
<property type="term" value="P:regulation of small GTPase mediated signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd00160">
<property type="entry name" value="RhoGEF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.900.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10190">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="InterPro" id="IPR001357">
<property type="entry name" value="BRCT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036420">
<property type="entry name" value="BRCT_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR035899">
<property type="entry name" value="DBL_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000219">
<property type="entry name" value="DH-domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR026817">
<property type="entry name" value="Ect2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001331">
<property type="entry name" value="GDS_CDC24_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR16777">
<property type="entry name" value="PTHR16777"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00533">
<property type="entry name" value="BRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12738">
<property type="entry name" value="PTCB-BRCT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00621">
<property type="entry name" value="RhoGEF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00292">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00325">
<property type="entry name" value="RhoGEF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48065">
<property type="entry name" value="SSF48065"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52113">
<property type="entry name" value="SSF52113"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50172">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00741">
<property type="entry name" value="DH_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50010">
<property type="entry name" value="DH_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0344">Guanine-nucleotide releasing factor</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0553">Oncogene</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0796">Tight junction</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Protein ECT2" id="PRO_0000080938">
<location>
<begin position="2"/>
<end position="914"/>
</location>
</feature>
<feature type="domain" description="BRCT 1" evidence="11">
<location>
<begin position="171"/>
<end position="260"/>
</location>
</feature>
<feature type="domain" description="BRCT 2" evidence="11">
<location>
<begin position="266"/>
<end position="354"/>
</location>
</feature>
<feature type="domain" description="DH" evidence="12">
<location>
<begin position="452"/>
<end position="641"/>
</location>
</feature>
<feature type="domain" description="PH">
<location>
<begin position="675"/>
<end position="794"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="378"/>
<end position="382"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="401"/>
<end position="405"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="7">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC/PRKCI" evidence="5 6 8 29">
<location>
<position position="359"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 8">
<location>
<position position="367"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="370"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1" evidence="4 20">
<location>
<position position="373"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="376"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1" evidence="22">
<location>
<position position="444"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="716"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="842"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1" evidence="4">
<location>
<position position="846"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="861"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="866"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="611"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041976" evidence="34 35 36 37">
<location>
<position position="44"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_041977" evidence="34 35 36 37">
<location>
<begin position="71"/>
<end position="101"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041978" evidence="38">
<original>GIPSPSLVSLPSFFERRSHTLSRSTTHLI</original>
<variation>ITHSVSTSNVIGFTKHVYVQRLNSTGGRSQYSWFQSVRHSAFRASFSEILEGNTDFSNFKKVLSKSSLTFVKN</variation>
<location>
<begin position="886"/>
<end position="914"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34703432." id="VAR_047064">
<original>S</original>
<variation>T</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035975" evidence="24">
<original>T</original>
<variation>P</variation>
<location>
<position position="833"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with RACGAP1. Abolishes targeting to the central spindle." evidence="26 32">
<original>T</original>
<variation>A</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with RACGAP1. Abolishes targeting to the central spindle." evidence="26 32">
<original>K</original>
<variation>A</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits homodimerization. Increases binding with RhoA and GEF activity." evidence="16">
<original>W</original>
<variation>R</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="mutagenesis site" description="2-fold increase in GEF activity." evidence="33">
<original>W</original>
<variation>A</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits its phosphorylation and anchorage-independent growth and invasion in cancer cells. Does not inhibit its GEF activity." evidence="29">
<original>T</original>
<variation>A</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit its Rho exchange activity. Increases interaction with RACGAP1. Does not inhibit anchorage-independent growth and invasion in cancer cells." evidence="18 20">
<original>T</original>
<variation>A</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit subcellular localization or homodimerization. Enhances its Rho exchange activity." evidence="18 20">
<original>T</original>
<variation>D</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="mutagenesis site" description="Shows both nuclear and cytoplasmic localization and activates its transforming activity." evidence="14">
<original>KRR</original>
<variation>AAA</variation>
<location>
<begin position="379"/>
<end position="381"/>
</location>
</feature>
<feature type="mutagenesis site" description="Shows both nuclear and cytoplasmic localization and activates its transforming activity." evidence="14">
<original>RKR</original>
<variation>AKA</variation>
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="mutagenesis site" description="Diminishes its phosphorylation status. Reduces its interaction with PLK1 and Rho exchange activity. Does not change its subcellular localization. Does not inhibit anchorage-independent growth and invasion in cancer cells." evidence="22">
<original>T</original>
<variation>A</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not reduce its interaction with PLK1, change its subcellular localization and Rho exchange activity." evidence="22">
<original>T</original>
<variation>D</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially releases inhibition." evidence="33">
<original>R</original>
<variation>C</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="mutagenesis site" description="2-fold increase in GEF activity." evidence="33">
<original>R</original>
<variation>D</variation>
<location>
<position position="570"/>
</location>
</feature>
<feature type="mutagenesis site" description="2-fold increase in GEF activity." evidence="33">
<original>A</original>
<variation>D</variation>
<location>
<position position="573"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of GEF activity and failure to support cytokinesis." evidence="33">
<original>R</original>
<variation>Q</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits activation of the transforming activity." evidence="14">
<original>PVQR</original>
<variation>AAAA</variation>
<location>
<begin position="596"/>
<end position="599"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of GEF activity and failure to support cytokinesis." evidence="33">
<original>P</original>
<variation>S</variation>
<location>
<position position="601"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on GEF activity but severely decreases ECT2 activation by RHOA. Localizes correctly but fails to rescue the cytokinesis defect caused by knockdown of endogenous ECT2 in contrast to the wild-type protein which rescues this defect." evidence="33">
<original>F</original>
<variation>A</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on GEF activity but severely decreases ECT2 activation by RHOA. Fails to rescue the cytokinesis defect caused by knockdown of endogenous ECT2 in contrast to the wild-type protein which rescues this defect." evidence="33">
<original>Y</original>
<variation>A</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="mutagenesis site" description="Marked increase in GEF activity and rescues the cytokinesis defect caused by depletion of endogenous ECT2. When expressed in a cancer cell line, causes faster cell proliferation than the wild-type protein." evidence="33">
<original>R</original>
<variation>Q</variation>
<location>
<position position="670"/>
</location>
</feature>
<feature type="mutagenesis site" description="More than 10-fold increase in GEF activity. Overexpression causes noticeable changes in interphase cell morphology such as cell rounding and formation of stress fibers, suggesting ectopic RhoA activation." evidence="33">
<original>P</original>
<variation>D</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="mutagenesis site" description="More than 10-fold increase in GEF activity. Overexpression causes noticeable changes in interphase cell morphology such as cell rounding and formation of stress fibers, suggesting ectopic RHOA activation." evidence="33">
<original>C</original>
<variation>K</variation>
<location>
<position position="796"/>
</location>
</feature>
<feature type="mutagenesis site" description="Diminishes its phosphorylation status." evidence="22">
<original>T</original>
<variation>A</variation>
<location>
<position position="846"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB14498." ref="5" evidence="39">
<original>I</original>
<variation>T</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB14498." ref="5" evidence="39">
<original>L</original>
<variation>F</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB14498." ref="5" evidence="39">
<original>E</original>
<variation>D</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="51"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="57"/>
<end position="59"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="63"/>
<end position="70"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="107"/>
<end position="112"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="115"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="124"/>
<end position="129"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="136"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="147"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="151"/>
<end position="159"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="173"/>
<end position="178"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="180"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="189"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="215"/>
<end position="224"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="225"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="241"/>
<end position="249"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="260"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="264"/>
<end position="266"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="270"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="283"/>
<end position="295"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="309"/>
<end position="313"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="315"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="330"/>
<end position="333"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="334"/>
<end position="343"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="349"/>
<end position="351"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="453"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="479"/>
<end position="483"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="495"/>
<end position="502"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="505"/>
<end position="522"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="532"/>
<end position="552"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="554"/>
<end position="567"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="569"/>
<end position="579"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="582"/>
<end position="584"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="589"/>
<end position="611"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="622"/>
<end position="634"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="635"/>
<end position="637"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="642"/>
<end position="657"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="664"/>
<end position="667"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="672"/>
<end position="687"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="691"/>
<end position="697"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="700"/>
<end position="706"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="726"/>
<end position="734"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="735"/>
<end position="737"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="738"/>
<end position="744"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="748"/>
<end position="758"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="761"/>
<end position="763"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="767"/>
<end position="773"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="780"/>
<end position="795"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="803"/>
<end position="807"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3L46"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4N40"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6L30"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q07139"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00033"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00062"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10579713"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14645260"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15254234"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15545273"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15642749"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16103226"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16129829"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16170345"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16236794"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16247472"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16495035"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19129481"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19468300"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19468302"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19617897"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21189248"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21373644"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25068414"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31888991"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10579713"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14587037"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305"/>
<sequence length="914" mass="103505" checksum="F40FC4F982FB8C78" modified="2011-11-16" version="4">MAENSVLTSTTGRTSLADSSIFDSKVTEISKENLLIGSTSYVEEEMPQIETRVILVQEAGKQEELIKALKTIKIMEVPVIKIKESCPGKSDEKLIKSVINMDIKVGFVKMESVEEFEGLDSPEFENVFVVTDFQDSVFNDLYKADCRVIGPPVVLNCSQKGEPLPFSCRPLYCTSMMNLVLCFTGFRKKEELVRLVTLVHHMGGVIRKDFNSKVTHLVANCTQGEKFRVAVSLGTPIMKPEWIYKAWERRNEQDFYAAVDDFRNEFKVPPFQDCILSFLGFSDEEKTNMEEMTEMQGGKYLPLGDERCTHLVVEENIVKDLPFEPSKKLYVVKQEWFWGSIQMDARAGETMYLYEKANTPELKKSVSMLSLNTPNSNRKRRRLKETLAQLSRETDVSPFPPRKRPSAEHSLSIGSLLDISNTPESSINYGDTPKSCTKSSKSSTPVPSKQSARWQVAKELYQTESNYVNILATIIQLFQVPLEEEGQRGGPILAPEEIKTIFGSIPDIFDVHTKIKDDLEDLIVNWDESKSIGDIFLKYSKDLVKTYPPFVNFFEMSKETIIKCEKQKPRFHAFLKINQAKPECGRQSLVELLIRPVQRLPSVALLLNDLKKHTADENPDKSTLEKAIGSLKEVMTHINEDKRKTEAQKQIFDVVYEVDGCPANLLSSHRSLVQRVETISLGEHPCDRGEQVTLFLFNDCLEIARKRHKVIGTFRSPHGQTRPPASLKHIHLMPLSQIKKVLDIRETEDCHNAFALLVRPPTEQANVLLSFQMTSDELPKENWLKMLCRHVANTICKADAENLIYTADPESFEVNTKDMDSTLSRASRAIKKTSKKVTRAFSFSKTPKRALRRALMTSHGSVEGRSPSSNDKHVMSRLSSTSSLAGIPSPSLVSLPSFFERRSHTLSRSTTHLI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

